Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow

Stem Cells and Development

Volumn 21, Issue 11, 2012, Pages 1897-1910

  Helledie, Torben ^a   Dombrowski, Christian ^a   Rai, Bina ^a   Lim, Zophia X H ^a   Hin, Ian Lee Hock ^b   Rider, David A ^a   Stein, Gary S ^c   Hong, Wanjin ^b   Van Wijnen, Andre J ^c   Hui, James H ^d   Nurcombe, Victor ^a,d   Cool, Simon M ^a,d  

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPARAN SULFATE;

ADULT; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; BONE DEFECT; BONE MARROW BIOPSY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL RENEWAL; CELL SUBPOPULATION; CELL SURVIVAL; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; EMBRYO CELL; EX VIVO STUDY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROARRAY ANALYSIS; MULTIPOTENT STEM CELL; OSSIFICATION; PELVIC GIRDLE; PRIORITY JOURNAL; TELOMERE;

ADOLESCENT; ADULT; ANIMALS; BIOLOGICAL MARKERS; BONE DISEASES; BONE MARROW; BONE REGENERATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION PROFILING; HEPARITIN SULFATE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MODELS, ANIMAL; RATS; RATS, NUDE; TELOMERE; TIME FACTORS; YOUNG ADULT;

EID: 84863944926     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0367     Document Type: Article

References (55)

1. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49. (Pubitemid 34742565)
2. Wagner J, T Kean, R Young, JE Dennis and AI Caplan. (2009). Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20:531-536.
3. Pittenger MF and BJ Martin. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20. (Pubitemid 38931831)
4. Miyahara Y, N Nagaya, M Kataoka, B Yanagawa, K Tanaka, H Hao, K Ishino, H Ishida, T Shimizu, et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12:459-465.
5. Petite H, V Viateau, W Bensaid, A Meunier, C de Pollak, M Bourguignon, K Oudina, L Sedel and G Guillemin. (2000). Tissue-engineered bone regeneration. Nat Biotechnol 18:959-963. (Pubitemid 32977376)
6. Quarto R, M Mastrogiacomo, R Cancedda, SM Kutepov, V Mukhachev, A Lavroukov, E Kon and M Marcacci. (2001). Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344:385-386. (Pubitemid 32107654)
7. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441. (Pubitemid 38586721)
8. Meirelles Lda S, AM Fontes, DT Covas and AI Caplan. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419-427.
9. Friedenstein AJ, RK Chailakhjan and KS Lalykina. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403.
10. Colter DC, I Sekiya and DJ Prockop. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 98:7841-7845. (Pubitemid 32642648)
11. Gronthos S and PJ Simmons. (1995). The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85:929-940.
12. Psaltis PJ, S Paton, F See, A Arthur, S Martin, S Itescu, SG Worthley, S Gronthos and AC Zannettino. (2010). Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. J Cell Physiol 223:530-540.
13. Gang EJ, D Bosnakovski, CA Figueiredo, JW Visser and RC Perlingeiro. (2007). SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751. (Pubitemid 46239610)
14. Ringden O, M Uzunel, I Rasmusson, M Remberger, B Sundberg, H Lonnies, HU Marschall, A Dlugosz, A Szakos, et al. (2006). Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397. (Pubitemid 43847148)
15. Boland GM, G Perkins, DJ Hall and RS Tuan. (2004). Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93:1210-1230. (Pubitemid 44264134)
16. Solchaga LA, K Penick, JD Porter, VM Goldberg, AI Caplan and JF Welter. (2005). FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrowderived mesenchymal stem cells. J Cell Physiol 203:398-409. (Pubitemid 40471774)
17. Tamama K, VH Fan, LG Griffith, HC Blair and A Wells. (2006). Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24:686-695. (Pubitemid 44464773)
18. Doucet C, I Ernou, Y Zhang, JR Llense, L Begot, X Holy and JJ Lataillade. (2005). Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205:228-236. (Pubitemid 41428905)
19. Digirolamo CM, D Stokes, D Colter, DG Phinney, R Class and DJ Prockop. (1999). Propagation and senescence of human marrow stromal cells in culture: a simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275-281. (Pubitemid 29530211)
20. Izadpanah R, D Kaushal, C Kriedt, F Tsien, B Patel, J Dufour and BA Bunnell. (2008). Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 68:4229-4238.
21. Walsh S, C Jefferiss, K Stewart, GR Jordan, J Screen and JN Beresford. (2000). Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone 27:185-195. (Pubitemid 30458810)
22. Quarto N, DC Wan and MT Longaker. (2008). Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). Bone 42:1040-1052.
23. Shi S, S Gronthos, S Chen, A Reddi, CM Counter, PG Robey and CY Wang. (2002). Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 20:587-591. (Pubitemid 34595152)
24. Simonsen JL, C Rosada, N Serakinci, J Justesen, K Stenderup, SI Rattan, TG Jensen and M Kassem. (2002). Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592-596. (Pubitemid 34595153)
25. Mauney JR, C Kirker-Head, L Abrahamson, G Gronowicz, V Volloch and DL Kaplan. (2006). Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrowderived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res A 79:464-475. (Pubitemid 44845159)
26. Burns JS, BM Abdallah, P Guldberg, J Rygaard, HD Schroder and M Kassem. (2005). Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65:3126-3135. (Pubitemid 40524593)
27. Brickman YG, MD Ford, JT Gallagher, V Nurcombe, PF Bartlett and JE Turnbull. (1998). Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 273:4350-4359. (Pubitemid 28103170)
28. Gallagher JT. (2001). Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 108:357-361. (Pubitemid 32730779)
29. Nurcombe V, MD Ford, JA Wildschut and PF Bartlett. (1993). Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103-106. (Pubitemid 23122755)
30. Rider DA, C Dombrowski, AA Sawyer, GH Ng, D Leong, DW Hutmacher, V Nurcombe and SM Cool. (2008). Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells 26:1598-1608.
31. Cawthon RM. (2002). Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47.
32. Guillot PV, C Gotherstrom, J Chan, H Kurata and NM Fisk. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654. (Pubitemid 46354223)
33. Ghosh D. (2002). Resampling methods for variance estimation of singular value decomposition analyses from microarray experiments. Funct Integr Genomics 2:92-97. (Pubitemid 41399307)
34. Bild AH, G Yao, JT Chang, Q Wang, A Potti, D Chasse, MB Joshi, D Harpole, JM Lancaster, et al. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357. (Pubitemid 43128862)
35. Villanueva J, DR Shaffer, J Philip, CA Chaparro, H Erdjument-Bromage, AB Olshen, M Fleisher, H Lilja, E Brogi, et al. (2006). Differential exoprotease activities confer tumorspecific serum peptidome patterns. J Clin Invest 116:271-284. (Pubitemid 43121812)
36. Huang da W, BT Sherman and RA Lempicki. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
37. Rai B, JL Lin, ZX Lim, RE Guldberg, DW Hutmacher and SM Cool. (2010). Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds. Biomaterials 31:7960-7970.
38. Sawyer AA, SJ Song, E Susanto, P Chuan, CX Lam, MA Woodruff, DW Hutmacher and SM Cool. (2009). The stimulation of healing within a rat calvarial defect by mPCLTCP/ collagen scaffolds loaded with rhBMP-2. Biomaterials 30:2479-2488.
39. Dombrowski C, SJ Song, P Chuan, X Lim, E Susanto, AA Sawyer, MA Woodruff, DW Hutmacher, V Nurcombe and SM Cool. (2009). Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells. Stem Cells Dev 18:661-670.
40. Bruder SP, N Jaiswal, NS Ricalton, JD Mosca, KH Kraus and S Kadiyala. (1998). Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 355 Suppl:S247-S256.
41. Jaiswal N, SE Haynesworth, AI Caplan and SP Bruder. (1997). Osteogenic differentiation of purified, cultureexpanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312. (Pubitemid 27065443)
42. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315-317. (Pubitemid 44269669)
43. Alter O, PO Brown and D Botstein. (2000). Singular value decomposition for genome-wide expression data processing and modeling. Proc Nat Acad Sci U S A 97:10101-10106.
44. Rider DA, T Nalathamby, V Nurcombe and SM Cool. (2007). Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells. J Mol Histol 38:449-458. (Pubitemid 350056776)
45. Shi S and S Gronthos. (2003). Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696-704. (Pubitemid 36899319)
46. Jones E and D McGonagle. (2008). Human bone marrow mesenchymal stem cells in vivo. Rheumatology 47:126-131. (Pubitemid 351168218)
47. Gronthos S, AC Zannettino, SJ Hay, S Shi, SE Graves, A Kortesidis and PJ Simmons. (2003). Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835. (Pubitemid 36582169)
48. Hudson JE, RJ Mills, JE Frith, G Brooke, P Jaramillo-Ferrada, EJ Wolvetang and JJ Cooper-White. (2011). A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo-and chondrogenic precursors. Stem Cells Dev 20:77-87.
49. Boiret N, C Rapatel, R Veyrat-Masson, L Guillouard, JJ Guerin, P Pigeon, S Descamps, S Boisgard and MG Berger. (2005). Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol 33:219-225. (Pubitemid 40164904)
50. Deschaseaux F and P Charbord. (2000). Human marrow stromal precursors are alpha 1 integrin subunit-positive. J Cell Physiol 184:319-325. (Pubitemid 30625494)
51. Stewart K, P Monk, S Walsh, CM Jefferiss, J Letchford and JN Beresford. (2003). STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res 313:281-290. (Pubitemid 37260435)
52. Peters A, D Toben, J Lienau, H Schell, HJ Bail, G Matziolis, GN Duda and K Kaspar. (2009). Locally applied osteogenic predifferentiated progenitor cells are more effective than undifferentiated mesenchymal stem cells in the treatment of delayed bone healing. Tissue Eng Part A 15:2947-2954.
53. Stenderup K, J Justesen, EF Eriksen, SI Rattan and M Kassem. (2001). Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res 16:1120-1129. (Pubitemid 32467156)
54. Sotiropoulou PA, SA Perez, M Salagianni, CN Baxevanis and M Papamichail. (2006). Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462-471. (Pubitemid 44464816)
55. Andersen DC, A Kortesidis, AC Zannettino, I Kratchmarova, L Chen, ON Jensen, B Teisner, S Gronthos, CH Jensen and M Kassem. (2011). Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells. Mol Cells 32:133-142.